Tapering off fludrocortisone should be done gradually, under the guidance of your prescriber, because the drug suppresses your body’s own aldosterone production and related hormonal pathways while you take it. Stopping abruptly can leave your system unable to retain enough sodium or excrete enough potassium, potentially causing dangerous electrolyte shifts, a steep drop in blood pressure, or both. There is no single universally published tapering schedule for fludrocortisone, partly because doses are already small (usually between 0.05 mg and 0.2 mg daily) and partly because the reason you are on it shapes how quickly you can come off. What follows is a practical walkthrough of the process, the signals to watch for, and the situations that call for extra caution.
Why You Cannot Just Stop
Fludrocortisone is a synthetic mineralocorticoid. Its main job is telling your kidneys to hold on to sodium and water while letting potassium go. That action raises blood volume and blood pressure, which is why doctors prescribe it for conditions like orthostatic hypotension and adrenal insufficiency. While the drug is doing that work, your body dials down its own aldosterone output. Research in healthy volunteers showed that fludrocortisone markedly suppresses renin activity and urinary aldosterone excretion, confirming that the body’s natural mineralocorticoid axis quiets down once an external source is present.1PubMed. Fludrocortisone suppression of sympathetic nervous activity Renin and aldosterone do not snap back the moment you remove the drug; they need days to weeks to ramp up again. If you stop cold, the gap between losing the drug’s effect and regaining your own aldosterone can leave you sodium-depleted, potassium-elevated, and lightheaded or worse.
Fludrocortisone also has a modest glucocorticoid effect. At the low doses typically prescribed, that glucocorticoid component is unlikely to heavily suppress the hypothalamic-pituitary-adrenal (HPA) axis the way high-dose prednisone does. But if you have been on it for months or years, or if you are also taking another corticosteroid, even mild HPA suppression adds up. A careful taper accounts for both the mineralocorticoid and the glucocorticoid dimensions.
A General Tapering Approach
Because fludrocortisone comes in 0.1 mg tablets, the smallest practical step down is usually 0.05 mg (half a tablet). A common strategy looks something like this:
- Starting dose 0.2 mg/day: Reduce to 0.15 mg for one to two weeks, then to 0.1 mg, then to 0.05 mg, then stop. Each step typically lasts one to four weeks depending on how you respond.
- Starting dose 0.1 mg/day: Drop to 0.05 mg for two to four weeks, then stop. Some clinicians extend that final step to six weeks if the patient has been on the drug for years or has adrenal insufficiency.
- Starting dose 0.05 mg/day: You are already at the lowest standard dose. Your doctor may try alternate-day dosing for a couple of weeks before stopping entirely, or simply discontinue with close monitoring.
These intervals are guidelines your prescriber will adjust based on lab results and symptoms. Nobody should memorize a table and taper on their own. The schedule exists to give your renin-angiotensin-aldosterone system time to wake back up, and different people’s systems wake up at different speeds.
What Your Doctor Will Monitor
Expect blood work and blood pressure checks at each step of the taper. The critical labs are serum sodium, serum potassium, and sometimes renin and aldosterone levels. A rising potassium or falling sodium at any step is a signal that your body has not yet compensated for the dose reduction. Your doctor will likely hold at the current dose or even step back up before trying again later.
Blood pressure monitoring matters, too, and orthostatic measurements are especially useful. That means checking your blood pressure lying down, then again after standing for a couple of minutes. If the standing reading drops steeply compared to lying down, your blood volume has not caught up yet. For people tapering because their orthostatic hypotension has improved, this test is the most direct way to see whether the improvement holds without medication support.
Weight can also be informative. Fludrocortisone promotes fluid retention, so a sudden drop in weight during a taper step sometimes reflects fluid loss before it shows up in symptoms. Tracking your weight daily at the same time of day gives you and your doctor an early heads-up.
Red Flags That the Taper Is Moving Too Fast
Some symptoms clearly signal that your body needs more time at the current dose or a step back up:
- Dizziness on standing: The classic sign that blood pressure is falling with position changes. If you had orthostatic symptoms before starting fludrocortisone and they return, the taper may be outpacing your recovery.
- Salt cravings: Intense, sudden cravings for salty foods can indicate your kidneys are losing sodium faster than usual.
- Muscle weakness or cramping: Rising potassium affects muscle and nerve function. Severe hyperkalemia is a medical emergency, so new or worsening cramping warrants a call to your doctor.
- Fatigue and nausea: These vague symptoms overlap with many conditions, but in the context of an active taper, they suggest the adrenal axis has not recovered enough.
- Heart palpitations: Potassium imbalance and volume depletion both affect heart rhythm. If you notice irregular or rapid heartbeats, seek medical attention promptly.
None of these symptoms mean the taper has failed permanently. They mean you need to slow down. In most cases, stepping back to the previous dose for another few weeks and then trying the reduction again is enough.
Condition-Specific Considerations
The reason you started fludrocortisone shapes how the taper goes and whether you can eventually stop altogether.
Orthostatic Hypotension
Many people begin fludrocortisone for orthostatic hypotension, and a sizable proportion end up discontinuing it at some point. In a large observational study following patients on fludrocortisone and midodrine, roughly a quarter of fludrocortisone users discontinued within the follow-up period, with a median time on the drug of about 268 days before stopping.2PubMed Central. Early Discontinuation of Treatment in Patients with Orthostatic Hypotension That does not mean everyone should try to stop after nine months; some of those discontinuations reflected side effects or unsatisfactory results. But it does suggest that fludrocortisone use for orthostatic hypotension is not always lifelong. If your orthostatic hypotension was triggered by a temporary factor, like a medication change, deconditioning, or a recoverable illness, a supervised taper is reasonable once the trigger has resolved.
Adrenal Insufficiency
If you have primary adrenal insufficiency (Addison’s disease), fludrocortisone is replacing an aldosterone supply your adrenal glands cannot produce. In that case, a complete taper off the drug is usually not on the table unless your adrenal function has been reassessed and found to have recovered, which is uncommon in autoimmune Addison’s disease. Dose adjustments still happen: your doctor may lower the dose if you develop ankle swelling, high blood pressure, or low potassium from too much mineralocorticoid effect, but stopping entirely requires confirmation that your own adrenals have resumed adequate aldosterone output.
Post-Surgical Recovery
People who have had one adrenal gland removed for conditions like primary aldosteronism sometimes need fludrocortisone temporarily while the remaining gland recovers. Most cases of low aldosterone after surgery are transient, but persistent cases can occur when the remaining gland’s aldosterone-producing zone was chronically suppressed and takes a long time to come back online.3PubMed Central. The Lingering Battle of Persistent Hypoaldosteronism Following Adrenalectomy for Primary Aldosteronism: A Case Report In this setting, your endocrinologist will attempt a taper every few months, using serum potassium and renin levels as the guide. If potassium rises above normal or renin stays suppressed, the remaining gland is not ready yet, and fludrocortisone continues.
POTS and Other Dysautonomias
Fludrocortisone is sometimes prescribed off-label for postural orthostatic tachycardia syndrome. The evidence base is thinner here, and many patients rotate through several medications. Tapering follows the same general principles, but heart rate on standing is the more relevant measure than blood pressure alone. If your standing heart rate stays below the threshold that defined your POTS diagnosis after a dose reduction, that is a favorable sign.
Supporting the Taper With Lifestyle Measures
A few non-drug strategies can make the transition smoother and help your body compensate as the fludrocortisone dose drops.
Keeping your salt intake adequate is important during a taper. The drug was holding sodium for you; as you reduce it, your kidneys start letting more sodium go. Your doctor may recommend a specific daily sodium target, often in the range of 2 to 3 grams of added sodium (roughly 5 to 8 grams of table salt) per day. That is higher than the general-population heart-healthy guideline, and it feels counterintuitive, but for someone coming off a mineralocorticoid, it cushions the landing.
Fluid intake matters similarly. Drinking enough water helps maintain blood volume, but you can overdo it. Excessive water without enough salt dilutes your sodium and makes the problem worse. Matching your fluids with adequate electrolytes is the goal, not simply drinking more.
Compression garments, particularly waist-high compression stockings or abdominal binders, can reduce blood pooling in your lower body when you stand. They do not replace the drug, but they blunt the orthostatic stress your body faces during the taper period. Many people find them most helpful during the last dose reduction and the first couple of weeks after stopping entirely.
Physical countermaneuvers also help. Things like crossing your legs and tensing your thigh muscles when you stand, rising slowly from a lying position (sit on the edge of the bed for a minute first), and avoiding prolonged standing without movement can all reduce lightheadedness during the vulnerable taper window.
How Long the Body Takes to Recover Full Mineralocorticoid Function
This is the question most people want answered with a number, and the honest answer is that it varies widely. For people who were on low doses for a few months to treat transient orthostatic hypotension, the renin-angiotensin-aldosterone system may normalize within a week or two of the last dose. For people on moderate doses for years, the recovery can stretch to several weeks or occasionally a few months.
Post-surgical patients represent the extreme. After adrenalectomy, the contralateral adrenal gland’s aldosterone-producing zone may have been suppressed for years by the overactive gland that was removed. Documented cases show that some patients need mineralocorticoid support for an extended period, with repeated taper attempts before the remaining gland can sustain adequate aldosterone independently.3PubMed Central. The Lingering Battle of Persistent Hypoaldosteronism Following Adrenalectomy for Primary Aldosteronism: A Case Report These are not typical cases, but they illustrate that recovery timelines are not one-size-fits-all.
During the recovery period, your renin level is actually a useful biomarker. Renin rises when the body senses it needs more aldosterone. A renin level that has normalized (neither suppressed nor excessively high) is a good signal that your endogenous aldosterone axis has returned to a steady state. Some endocrinologists check renin and aldosterone a few weeks after the last dose to confirm this before declaring the taper complete.
Common Mistakes People Make When Tapering
The most frequent mistake is self-tapering without telling a doctor. Because the tablets are tiny and the doses are small, some people assume the drug is not “serious” enough to require supervised withdrawal. But mineralocorticoid withdrawal affects potassium, sodium, blood pressure, and heart rhythm at the same time. Lab abnormalities can develop before symptoms do, meaning you might be in a quietly dangerous state without feeling it yet.
Another common error is cutting sodium intake at the same time as reducing fludrocortisone, often because a person is simultaneously trying to eat a healthier diet. The timing is unfortunate. During a taper is not the moment to start restricting salt. You can revisit your sodium goals once you are stable off the drug and your labs confirm your electrolytes are self-regulating.
Some people also confuse fludrocortisone with more familiar corticosteroids like prednisone and expect the same kind of taper experience. Prednisone tapers are dominated by HPA-axis suppression and cortisol deficiency, which produces fatigue, joint pain, and sometimes a withdrawal syndrome that mimics the original inflammatory disease. Fludrocortisone tapers are dominated by salt and water balance. The symptoms, the labs to watch, and the pace of the taper are different. Treating one like the other leads to misplaced anxiety in some areas and not enough caution in others.
When Restarting Becomes Necessary
Not every taper succeeds on the first try. If your condition is chronic, like neurogenic orthostatic hypotension from an underlying autonomic disorder, you may attempt a taper only to find that symptoms return and labs shift adversely. That does not mean you failed; it means the underlying condition still requires treatment. In the large cohort study mentioned earlier, roughly three percent of fludrocortisone users underwent a treatment change rather than simply discontinuing, suggesting that a minority shift to alternative medications rather than coming off pharmacotherapy entirely.2PubMed Central. Early Discontinuation of Treatment in Patients with Orthostatic Hypotension
If you do need to restart, going back to the pre-taper dose is the standard approach. Your doctor may then try again in a few months, especially if the original reason for the taper was a side effect like high blood pressure or low potassium. Sometimes a partial taper works well: reducing from, say, 0.1 mg to 0.05 mg and staying there long-term, which may relieve side effects while still providing enough mineralocorticoid support to keep symptoms at bay.
Interactions to Revisit During a Taper
While you are on fludrocortisone, some of your other medications may have been dose-adjusted to account for its effects. Once you start tapering, those interactions shift. A few worth flagging for your prescriber:
- Potassium-sparing diuretics: Drugs like spironolactone directly oppose fludrocortisone’s mineralocorticoid action. If you are on both, the balance between them changes as the fludrocortisone dose drops.
- Potassium supplements: If you were taking supplemental potassium to offset fludrocortisone-driven potassium loss, your need for that supplement decreases as the dose comes down. Continuing the same supplement dose while tapering fludrocortisone can push potassium too high.
- Blood pressure medications: Fludrocortisone raises blood pressure. If you are also on antihypertensives, reducing fludrocortisone may lower your blood pressure enough that the antihypertensive dose needs adjusting too, or you could end up with excessive drops in pressure from the combined effect.
- NSAIDs: Non-steroidal anti-inflammatory drugs can independently affect sodium and potassium handling in the kidneys. Their interaction with fludrocortisone is modest at full dose, but the margin gets thinner during a taper when your electrolyte balance is already in flux.
A medication review at the start of any taper catches these issues before they cause problems. If you take several of these drug classes, your doctor may schedule more frequent lab checks during the reduction.